WHO set to resume hydroxychloroquine trial in battle on Coronavirus

The World Health Organization (WHO) is set to resume its trial of hydroxychloroquine for potential use against the Covid-19, its head Tedros Adhanom Ghebreyesus said today, after testing was suspended due to health concerns.

The U.N. body had paused its large study of the anti-malarial drug to treat COVID-19 due to fears it increased death rates and irregular heartbeats in patients.

But Tedros told an online media briefing that WHO experts had advised the continuation of all trials including hydroxychloroquine, whose highest-profile backer for its use against the coronavirus has been U.S. President Donald Trump.

WHO officials said they were especially worried about outbreaks in Latin America and in Haiti, one of the world’s poorest nations, where infections have been spreading rapidly.

WHO set to resume hydroxychloroquine trial in battle on Coronavirus via @MasterMindUpdate
  • Save
Share via
Copy link